The Impact of Tumor Volume and Radiotherapy Dose on Outcome in Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck Treated With Stereotactic Body Radiation Therapy

Documenti analoghi

• Stereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer
  di: Stanisce, Luke, et al.
  Pubblicazione: (2018)
• Stereotactic ablative radiotherapy (SABR) for recurrent and previously irradiated head and neck cancers
  di: Anand, Anil Kumar, et al.
  Pubblicazione: (2020)
• Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer
  di: Thomas, Joel, et al.
  Pubblicazione: (2020)
• Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer
  di: Vargo, John A., et al.
  Pubblicazione: (2014)
• Dose-response modeling the risk of carotid bleeding events after stereotactic body radiation therapy for previously irradiated head and neck cancer
  di: Ling, Diane C., et al.
  Pubblicazione: (2019)